Unknown

Dataset Information

0

Analysis of the prostate cancer-susceptibility locus HPC20 in 172 families affected by prostate cancer.

ABSTRACT: A recent study of hereditary prostate cancer has provided evidence for a prostate cancer-susceptibility locus, HPC20, which maps to 20q13. To assess further the potential contribution of this locus to prostate cancer susceptibility, we studied 172 unrelated families affected by prostate cancer, using 17 polymorphic markers across a 98.5-cM segment of chromosome 20 that contains the candidate region. Parametric analysis, allowing for heterogeneity, resulted in an overall HLOD score of 0.09 (P=.39) at D20S171, under the assumption of linkage in 6% of families. Mode-of-inheritance-free analysis of the entire data set resulted in a maximal Zlr score of 0.76 (LOD 0.13; P=.22) at the same location. The strongest evidence for linkage was seen in the subset of 16 black families (LOD 0.86; Zlr=1.99; P=.023) between markers D20S893 and D20S120, near the putative location of HPC20. Although some positive results were observed, our linkage study does not provide statistically significant support for the existence of a prostate cancer-susceptibility locus HPC20 at 20q13.

SUBMITTER: Bock CH 

PROVIDER: S-EPMC1274493 | biostudies-literature | 2001 Mar

REPOSITORIES: biostudies-literature

Json Xml
altmetric image

Publications

Analysis of the prostate cancer-susceptibility locus HPC20 in 172 families affected by prostate cancer.

Bock C H CH   Cunningham J M JM   McDonnell S K SK   Schaid D J DJ   Peterson B J BJ   Pavlic R J RJ   Schroeder J J JJ   Klein J J   French A J AJ   Marks A A   Thibodeau S N SN   Lange E M EM   Cooney K A KA  

American journal of human genetics 20010206 3

A recent study of hereditary prostate cancer has provided evidence for a prostate cancer-susceptibility locus, HPC20, which maps to 20q13. To assess further the potential contribution of this locus to prostate cancer susceptibility, we studied 172 unrelated families affected by prostate cancer, using 17 polymorphic markers across a 98.5-cM segment of chromosome 20 that contains the candidate region. Parametric analysis, allowing for heterogeneity, resulted in an overall HLOD score of 0.09 (P=.39  ...[more]

Similar Datasets

Unknown A novel prostate cancer susceptibility locus at 19q13.
| S-EPMC2803342 | biostudies-literature
Unknown Segregation analyses of 1,476 population-based Australian families affected by prostate cancer.
| S-EPMC1226101 | biostudies-literature
Unknown Genome-wide linkage analyses of hereditary prostate cancer families with colon cancer provide further evidence for a susceptibility locus on 15q11-q14.
| S-EPMC2921483 | biostudies-literature
Unknown Genomewide linkage study in 1,176 affected sister pair families identifies a significant susceptibility locus for endometriosis on chromosome 10q26.
| S-EPMC1226203 | biostudies-literature
Unknown Evidence for a prostate cancer-susceptibility locus on chromosome 20.
| S-EPMC1287105 | biostudies-literature
Unknown Identification of a new prostate cancer susceptibility locus on chromosome 8q24.
| S-EPMC3430510 | biostudies-literature
Unknown Biology and Clinical Implications of the 19q13 Aggressive Prostate Cancer Susceptibility Locus.
| S-EPMC6091222 | biostudies-literature
Unknown Hereditary prostate cancer in African American families: linkage analysis using markers that map to five candidate susceptibility loci.
| S-EPMC2410149 | biostudies-literature
Unknown Evaluation of ACMG-Guideline-Based Variant Classification of Cancer Susceptibility and Non-Cancer-Associated Genes in Families Affected by Breast Cancer.
| S-EPMC4863474 | biostudies-literature
Unknown Family-based association analysis of 42 hereditary prostate cancer families identifies the Apolipoprotein L3 region on chromosome 22q12 as a risk locus.
| S-EPMC2935853 | biostudies-literature